• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.58% Nasdaq Down1.64%

    Regulus Therapeutics Inc. (RGLS)

    -NGM
    18.87 Down 0.55(2.83%) 10:13AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Net Income (9,798) (11,973) (12,741) (1,927)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation757  779  797  816  
    Adjustments To Net Income(158)731  3,541  (1,769)
    Changes In Accounts Receivables50  61  (61)16  
    Changes In Liabilities111  1,255  (119)(4,600)
    Changes In Inventories -   -   -   -  
    Changes In Other Operating Activities236  (875)(446)(1,850)
    Total Cash Flow From Operating Activities (8,802) (10,022) (9,029) (9,314)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(389)(656)(75)(192)
    Investments8,987  12,227  (10,408)(6,184)
    Other Cash flows from Investing Activities(19)(34) -  11  
    Total Cash Flows From Investing Activities 8,579   11,537   (10,483) (6,365)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -   -  
    Sale Purchase of Stock193  69  10,215  12  
    Net Borrowings(36)(36)(34)(16)
    Other Cash Flows from Financing Activities -   -   -   -  
    Total Cash Flows From Financing Activities 157   33   10,181   (4)
    Effect Of Exchange Rate Changes -   -   -   -  
    Change In Cash and Cash Equivalents (66) 1,548   (9,331) (15,683)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.